MedPath

广州白云山汉方现代药业有限公司

Ownership
-
Established
1998-09-24
Employees
-
Market Cap
-
Website
http://www.byshf.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

54

NMPA:54

Drug Approvals

Carbocysteine Tablets

Product Name
羧甲司坦片
Approval Number
国药准字H44023309
Approval Date
May 14, 2024
NMPA

Soybean Oil(For Injection)

Product Name
大豆油(供注射用)
Approval Number
国药准字H10983231
Approval Date
May 14, 2024
NMPA

Linoleic Acid

Product Name
亚油酸
Approval Number
国药准字H44024405
Approval Date
May 14, 2024
NMPA

Scopolamine Butylbromide Capsules

Product Name
丁溴东莨菪碱胶囊
Approval Number
国药准字H44023471
Approval Date
May 14, 2024
NMPA

Scopolamine Hydrobromide

Product Name
氢溴酸东莨菪碱
Approval Number
国药准字H44023476
Approval Date
May 14, 2024
NMPA

Licorzine Capsules

Product Name
甘草锌胶囊
Approval Number
国药准字H44024403
Approval Date
May 14, 2024
NMPA

Tolbutamide

Product Name
甲苯磺丁脲
Approval Number
国药准字H20066142
Approval Date
May 14, 2024
NMPA

Levodopa Capsules

Product Name
左旋多巴胶囊
Approval Number
国药准字H44023481
Approval Date
May 14, 2024
NMPA

Thymopentin

Product Name
胸腺五肽
Approval Number
国药准字H20059773
Approval Date
May 14, 2024
NMPA

Ethyl Linoleate

Product Name
亚油酸乙酯
Approval Number
国药准字H44024728
Approval Date
May 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath